Therefore, in short summary, an overall metabolically healthier phenotype including the reduced tendency of acquiring hyperglycemia and dyslipidemia in Cgref1-/- mice indicated that Cgref1 might be an underlying factor of metabolic disease pathogenesis. This evidence concerns the gene CGREF1 and metabolic disease.